Citations

Mayo Clinic

Showing 10 of 108523 citations.

Harmonizing immune cell sequences for computational analysis with large language models
Alsaafin, Areej , Tizhoosh, Hamid R. , Tizhoosh, Hamid R

Biology Methods and Protocols | July 30, 2024 | Volume: 9 | Issue: 1 | Pages: No page available

10.1093/biomethods/bpae055 | PMID 39290987 Get It

Abstract We present SEQuence Weighted Alignment for Sorting and Harmonization (Seqwash), an algorithm designed to process sequencing profiles utilizing large language models. Seqwash harmonizes immune cell sequences into a unified representation, empowering LLMs to embed meaningful patterns while eliminating irrelevant information. Evaluations using immune cell sequencing data showcase Seqwash’s efficacy in standardizing profiles, leading to improved feature quality and enhanced performance in both supervised and unsupervised downstream tasks for sequencing data.
Safety of intracranial venous stenting in patients with nickel allergy
McGrath, Margaret , Clarke, Julian , Midtlien, Jackson P , Ali, Haider , Amans, Matthew R. , Hui, Ferdinand , Brinjikji, Waleed , Levitt, Michael R. , Fargen, Kyle M , Amans, Matthew , Hui, Ferdinand , Levitt, Michael R , McGrath, Margaret , Fargen, Kyle M

Journal of NeuroInterventional Surgery | July 30, 2024 | Volume: 17 | Issue: 8 | Pages: 899-901

10.1136/jnis-2024-022094 | PMID 39084853 Get It

Background Nickel hypersensitivity is the most common metal related allergy. Nickel containing alloys are frequently used in endovascular devices. The use of intracranial stents in patients with nickel hypersensitivity appears to be safe, but these small series only evaluated arterial stent placement. This case series aimed to assess the safety of intracranial venous stent placement in patients with documented nickel allergy. Methods In this retrospective multicenter case series, patients with idiopathic intracranial hypertension and documented nickel allergy underwent treatment with a permanently implanted nickel containing stent in the dural venous sinuses. Results Nine patients with nickel allergy were included. All patients reported clinical improvement in their idiopathic intracranial hypertension symptoms. Of the five patients who had follow-up intracranial venous imaging, all stents remained patent. No patients experienced intraoperative, postoperative, or long term procedure related complications, with follow-up ranging from 1.8 weeks to 49.1 months. Conclusion In this limited case series, the use of nickel containing stents in intracranial venous sinuses in patients with nickel allergy did not result in any allergic reaction or adverse outcome.
Current laboratory testing practices for mismatch repair deficiency and microsatellite instability testing: A survey-based review of current laboratory practices
Austin, Amy, Broaddus, Russell R. , Souers, Rhona J., Kane, Megan E , Kolhe, Ravindra , Miller, Dylan V. , Moncur, Joel T., Ramkissoon, Shakti, Trembath, Dimitri G. , Kolhe, Ravindra , Ramkissoon, Shakti, Tafe, Laura J. , Graham, Rondell P.

American Journal of Clinical Pathology | July 30, 2024 | Volume: 163 | Issue: 1 | Pages: 60-68

10.1093/ajcp/aqae094 | PMID 39078096 Get It

Abstract Objectives To describe mismatch repair (MMR) and microsatellite instability (MSI) testing practices in laboratories using the College of American Pathologists (CAP) MSI/MMR proficiency testing programs prior to the 2022 publication of the MSI/MMR practice guidelines copublished by CAP and the Association of Molecular Pathology (AMP). Methods Data from supplemental questionnaires provided with the 2020-B MSI/MMR programs to 542 laboratories across different practice settings were reviewed. Questionnaires contained 21 questions regarding the type of testing performed, specimen/tumor types used for testing, and clinical practices for checkpoint blockade therapy. Results Domestic laboratories test for MSI/MMR more often than international laboratories (P = .04) and academic hospitals/medical centers test more frequently than nonhospital sites/clinics (P = .03). The most commonly used testing modality is immunohistochemistry, followed by polymerase chain reaction, then next-generation sequencing. Most laboratories (72.6%; 347/478) reported awareness of the use of immune checkpoint inhibitor therapy for patients with high MSI or MMR-deficient results. Conclusions The results demonstrate the state of MMR and MSI testing in laboratories prior to the publication of the CAP/AMP best practice guidelines, highlighting differences between various laboratory types. The findings indicate the importance of consensus guidelines and provide a baseline for comparison after their implementation.
Engineered transcription activator-like effector dimer proteins confer DNA loop-dependent gene repression comparable to Lac repressor
Becker, Nicole A. , Peters, Justin P. , Lewis, Elizabeth B , Daby, Camden L. , Maher, L. James , Lewis, Elizabeth, Clark, Karl, III, Louis James Maher , Lewis, Elizabeth, Clark, Karl J.

Nucleic Acids Research | July 30, 2024 | Volume: 52 | Issue: 16 | Pages: 9996-10004

10.1093/nar/gkae656 | PMID 39077947 Get It

Abstract Natural prokaryotic gene repression systems often exploit DNA looping to increase the local concentration of gene repressor proteins at a regulated promoter via contributions from repressor proteins bound at distant sites. Using principles from the Escherichia coli lac operon we design analogous repression systems based on target sequence-programmable Transcription Activator-Like Effector dimer (TALED) proteins. Such engineered switches may be valuable for synthetic biology and therapeutic applications. Previous TALEDs with inducible non-covalent dimerization showed detectable, but limited, DNA loop-based repression due to the repressor protein dimerization equilibrium. Here, we show robust DNA loop-dependent bacterial promoter repression by covalent TALEDs and verify that DNA looping dramatically enhances promoter repression in E. coli. We characterize repression using a thermodynamic model that quantitates this favorable contribution of DNA looping. This analysis unequivocally and quantitatively demonstrates that optimized TALED proteins can drive loop-dependent promoter repression in E. coli comparable to the natural LacI repressor system. This work elucidates key design principles that set the stage for wide application of TALED-dependent DNA loop-based repression of target genes.
What Is the Role of Glucagon-Like Peptide 1 Signaling in the Nervous System and Its Potential Neuroprotective Effects?
Turcano, Pierpaolo , Savica, Rodolfo , Benarroch, Eduardo E. , Benarroch, Eduardo

Neurology | July 30, 2024 | Volume: 103 | Issue: 4 | Pages: No page available

10.1212/wnl.0000000000209781 | PMID 39079072 Get It

Clinicopathologic and Neuroimaging Correlations of Nonverbal Oral Apraxia in Patients With Neurodegenerative Disease
García-Guáqueta, Danna P. , Botha, Hugo , Utianski, Rene L. , Duffy, Joseph R. , Clark, Heather M. , Meade, Gabriela , Machulda, Mary M. , Dickson, Dennis W. , Pham, Nha Trang Thu, Whitwell, Jennifer L. , Josephs, Keith A. , Clark, Heather M , Meade, Gabriela , Utianski, Rene L , Dickson, Dennis W , Botha, Hugo , Duffy, Joseph R , Machulda, Mary M

Neurology | July 30, 2024 | Volume: 103 | Issue: 4 | Pages: No page available

10.1212/wnl.0000000000209717 | PMID 39079070 Get It

Incidence of Primary Progressive Apraxia of Speech and Primary Progressive Aphasia in Olmsted County, MN, 2011–2022
Turcano, Pierpaolo , Whitwell, Jennifer L. , Duffy, Joseph R. , Machulda, Mary M. , Josephs, Keith A. , Savica, Rodolfo , Mullan, Aidan, Josephs, Keith A , Savica, Rodolfo , Duffy, Joseph R , Machulda, Mary M , Mullan, Aidan F.

Neurology | July 30, 2024 | Volume: 103 | Issue: 4 | Pages: No page available

10.1212/wnl.0000000000209693 | PMID 39079073 Get It

Rectal Relief: Proton Therapy's Impact on Urgency and Frequency
Attia, Albert, Hoppe, Bradford S. , Hoppe, Bradford S , Saifi, Omran

Journal of Clinical Oncology | July 30, 2024 | Volume: 42 | Issue: 31 | Pages: 3762-3763

10.1200/jco.24.01162 | PMID 39079065 Get It

Reply to A. Sartore-Bianchi et al
Battaglin, Francesca , Ou, Fang‐Shu , Innocenti, Federico , Lenz, Heinz‐Josef , Ou, Fang-Shu

Journal of Clinical Oncology | July 30, 2024 | Volume: 42 | Issue: 30 | Pages: 3632-3634

10.1200/jco.24.01086 | PMID 39079060 Get It

Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation
Ahmed, Raheel , Jamil, Yumna , Ramphul, Kamleshun , Mactaggart, Sebastian , Bilal, Maham , Shi, Rui , Azzu, Alessia , Memon, Rahat A , Sakthivel, Hemamalini, Khattar, Rajdeep , Wells, Athol U. , Baksi, John Arun, Wechalekar, Kshama , Sharma, Rakesh, Ahmed, Raheel , Dulay, Mansimran Singh , Okafor, Joseph , Kouranos, Vasileios , Chahal, C. Anwar A.

Pacing and Clinical Electrophysiology | July 30, 2024 | Volume: 47 | Issue: 10 | Pages: 1394-1403

10.1111/pace.15051 | PMID 39078380 Get It

AbstractIntroductionIn patients with cardiac sarcoidosis (CS), implantable cardioverter‐defibrillators (ICDs) are important for preventing sudden cardiac death. This study aimed to investigate sex disparities in CS patients undergoing ICD implantation.MethodsThe 2016–2020 National Inpatient Sample (NIS) database compared the characteristics and outcomes of males and females with CS receiving ICDs.ResultsAmong 760 CS patients who underwent inpatient ICD implantation, 66.4% were male. Males were younger (55.0 vs. 56.9 years, p < .01), had higher rates of diabetes (31.7% vs. 21.6%, p < .01) and chronic kidney disease (CKD) (16.8% vs. 7.8%, p < .01) but lower prevalence of atrial fibrillation (AF) (11.9% vs. 23.5%, p < .01), sick sinus syndrome (4.0% vs. 7.8%, p = .024), ventricular fibrillation (VF) (9.9% vs. 15.7%, p = .02), and black ancestry (31.9% vs. 58.0%, p < .01). Unadjusted major adverse cardiovascular events (MACE), defined as a composite of in‐hospital death, myocardial infarction (MI), and ischemic stroke, was higher in females (11.8% vs. 6.9%, p = .024), but when adjusted for age and tCharlson Comorbidity Index (CCI), females demonstrated significantly lower odds of experiencing MACE (aOR: 0.048, 95% CI: 0.006–0.395, p = .005). Incidence of acute kidney injury (AKI) post‐ICD was significantly lower in females (15.7% vs. 23.8%, p = .01) as was the adjusted odds (aOR: 0.282, 95% CI: 0.146–0.546, p < .01). There was comparable mean length of stay and hospital charges.ConclusionICD utilization in CS patients is more common among males, who have a higher prevalence of diabetes and CKD but a lower prevalence of AF, sick sinus syndrome, and VF. Adjusted MACE and AKI were significantly lower in females.